| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |